[Immunohistological study of the mechanism of cytotoxic effect against cutaneous metastatic malignant melanoma by intralesional injection with anti-monosialoganglioside mouse monoclonal antibody (MAb 202)].
Ota
T
T
Imamura
T
T
Hamanaka
S
S
Nishioka
K
K
Tai
T
T
Kawashima
I
I
Irie
R F
RF
Asagami
C
C
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003165:Complement System Proteins / Q000502:physiology; D005732:Gangliosides / Q000276:immunology*; D006801:Humans; D007075:Immunoglobulin M / Q000627:therapeutic use; D007279:Injections, Subcutaneous; D008297:Male; D008545:Melanoma / Q000473:pathology / Q000628:therapy*; D008875:Middle Aged; D012878:Skin Neoplasms / Q000473:pathology / Q000628:therapy*
D000911:Antibodies, Monoclonal; D005732:Gangliosides; D007075:Immunoglobulin M; C025447:sialogangliosides; D003165:Complement System Proteins